Ryo Takada

Fukuyama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A Retrospective Multicenter Study to Examine the Risk Factors for Febrile Neutropenia during Amrubicin Hydrochloride Therapy for Recurrent Small Cell Lung Cancer

A Retrospective Multicenter Study to Examine the Risk Factors for Febrile Neutropenia during Amrubicin Hydrochloride Therapy for Recurrent Small Cell Lung Cancer

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Published: April 01, 2026

Baseline serum albumin level as a predictive factor for the efficacy of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer: a retrospective cohort study.

Baseline serum albumin level as a predictive factor for the efficacy of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer: a retrospective cohort study.

Journal: Journal of pharmaceutical health care and sciences

Published: October 06, 2025

Association between the Pretreatment Body Mass Index and Anamorelin's Efficacy in Patients with Cancer Cachexia: A Retrospective Cohort Study.

Association between the Pretreatment Body Mass Index and Anamorelin's Efficacy in Patients with Cancer Cachexia: A Retrospective Cohort Study.

Journal: Acta medica Okayama

Published: April 30, 2025

Pneumocystis Pneumonia in a Patient With Colorectal Cancer Receiving Bevacizumab and mFOLFOX6 Therapy.

Pneumocystis Pneumonia in a Patient With Colorectal Cancer Receiving Bevacizumab and mFOLFOX6 Therapy.

Journal: Cancer diagnosis & prognosis

Published: February 20, 2025

Effect of the thyroid transcription factor 1 expression and treatment discontinuation due to adverse events on progression-free survival in patients with advanced non-squamous non-small cell lung cancer treated with pembrolizumab plus pemetrexed and platinum chemotherapy: a Japanese four-hospital, retrospective study.

Effect of the thyroid transcription factor 1 expression and treatment discontinuation due to adverse events on progression-free survival in patients with advanced non-squamous non-small cell lung cancer treated with pembrolizumab plus pemetrexed and platinum chemotherapy: a Japanese four-hospital, retrospective study.

Journal: American journal of cancer research

Published: April 18, 2024

Stage IV renal cell carcinoma achieves pathologic complete response after two ipilimumab plus nivolumab courses despite severe immune-related adverse events: a case report.

Stage IV renal cell carcinoma achieves pathologic complete response after two ipilimumab plus nivolumab courses despite severe immune-related adverse events: a case report.

Journal: Journal of pharmaceutical health care and sciences

Published: February 29, 2024

Risk factors for thromboembolism during first-line treatment of patients with unresectable advanced or recurrent colorectal cancer: a retrospective short study.

Risk factors for thromboembolism during first-line treatment of patients with unresectable advanced or recurrent colorectal cancer: a retrospective short study.

Journal: Journal of pharmaceutical health care and sciences

Published: March 27, 2023

Effect of renal clearance on vancomycin area under the concentration-time curve deviations in critically ill patients.

Effect of renal clearance on vancomycin area under the concentration-time curve deviations in critically ill patients.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: February 17, 2023

Comparison of the Treatment Persistence Among 4 Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A 5-Year Retrospective Cohort Study.

Comparison of the Treatment Persistence Among 4 Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A 5-Year Retrospective Cohort Study.

Journal: Journal of clinical pharmacology

Published: August 14, 2022

Immune checkpoint inhibitor therapy and elevated levels of C-reactive protein associated with COVID-19 aggravation in patients with lung cancer.

Immune checkpoint inhibitor therapy and elevated levels of C-reactive protein associated with COVID-19 aggravation in patients with lung cancer.

Journal: Journal of pharmaceutical health care and sciences

Published: April 27, 2022

Utility of a Score for Predicting Glomerular Filtration Rate Overestimation in Patients with Cardiovascular and Renal Diseases and Their Risk Factors.

Utility of a Score for Predicting Glomerular Filtration Rate Overestimation in Patients with Cardiovascular and Renal Diseases and Their Risk Factors.

Journal: Internal medicine (Tokyo, Japan)

Published: January 17, 2022

Efficacy and Safety of Linaclotide in Elderly Patients

Efficacy and Safety of Linaclotide in Elderly Patients

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Published: February 01, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026